Al Jalila’s AED 19.25m cancer support: what Dubai patients should do first

For a family in Dubai facing a child’s cancer diagnosis, Al Jalila Foundation’s AED 19.25 million support since 2015 means one practical step comes before fundraising: check whether the child can enter a Dubai Health pathway and apply for charity support through A’awen.

The figure, reported by Gulf News on 26 September 2026, covers 297 children. That is an implied average of about AED 64,815 per child. It is a funding signal, not a price list. Paediatric oncology bills vary by diagnosis, inpatient days, chemotherapy protocol, surgery, imaging, infection admissions and imported medicines.

What Dubai families should check first

The first question is regulatory and financial. Dubai care is regulated by the Dubai Health Authority (DHA). If the child is insured in Dubai, the family should ask the insurer and hospital for written pre-authorisation before paying deposits for chemotherapy, scans or admission. The written answer should state the diagnosis, covered facility, approved treatment cycles, exclusions, co-pay and whether the case falls under any DHA-mandated patient support pathway.

DHA’s BASMAH Programme covers screening, early detection and treatment support for cancer and hepatitis B and C through DHA-accredited centres for eligible patients. DHA’s earlier benefit circular states that Dubai’s Cancer Patient Support Program was designed so eligible Dubai residents could access cancer screening and treatment irrespective of the usual annual coverage limit. Families should still ask for case-specific approval because eligibility depends on residency, insurance status, diagnosis and treating centre.

• Ask the hospital for a written treatment plan with diagnosis code, expected cycles, admission risk and medicine names.
• Ask the insurer for written pre-authorisation, not verbal call-centre guidance.
• Ask Dubai Health or the treating hospital whether the case can be submitted to A’awen.
• Keep Emirates ID, residence visa, insurance card, pathology report, imaging report and salary or income documents ready.

Where Al Jalila fits in

A’awen is Al Jalila Foundation’s patient treatment support programme for UAE-based patients receiving care through Dubai Health facilities. Applications are made through a Dubai Health account or verified UAE Pass, according to Al Jalila Foundation. That matters because families who start treatment outside the eligible network may later find that charity support cannot be applied cleanly to earlier bills.

Al Jalila Children’s Hospital, part of Dubai Health, provides paediatric oncology care for children up to 18 years, according to Dubai Health. The hospital says its paediatric oncology department treats children with cancer through inpatient and outpatient services. For families, the operational point is simple: get the referral, cost estimate and charity application route aligned before the first high-cost admission where possible.

Families should treat the AED 64,815 implied average as a benchmark for asking questions, not as an entitlement. A child with leukaemia, lymphoma or a solid tumour can have different cost drivers. If a hospital cannot give a fixed price, ask for a staged estimate: first diagnostic work-up, first treatment block, likely inpatient exposure and medicines requiring separate approval.

Abu Dhabi and northern emirates checks

For Abu Dhabi or Al Ain patients, the regulator is the Department of Health Abu Dhabi (DOH). A family considering treatment in Dubai should ask whether the Abu Dhabi insurer will approve an out-of-emirate provider, and whether a DOH-licensed oncology team needs to issue the referral first. UAE nationals and Abu Dhabi residents with government-linked coverage should confirm the rule with their payer before moving files.

For Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain, the regulator is the Ministry of Health and Prevention (MOHAP), with Emirates Health Services operating public facilities. Families in the northern emirates should ask the current treating facility for a referral letter, insurer approval and confirmation that the receiving Dubai provider is licensed for paediatric oncology. Moving without those documents can delay approvals by days or weeks.

The practical close is verification. Before choosing a provider, search the UAE Open Healthcare Directory for licensed oncology providers, then confirm the facility licence, treating speciality, insurance network and referral requirements directly with the provider and regulator.